Futura Medical plc (AIM:FUM)

Market Cap	29.47M
Revenue (ttm)	13.93M
Net Income (ttm)	1.29M
Shares Out	303.83M
EPS (ttm)	0.00
PE Ratio	23.66
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	526,363
Average Volume	699,519
Open	9.60
Previous Close	9.86
Day's Range	8.97 - 9.81
52-Week Range	7.00 - 45.56
Beta	0.74
RSI	39.06
Earnings Date	Sep 11, 2025

About Futura Medical

Futura Medical plc research, develops, and sells pharmaceutical and healthcare products for sexual health. Its lead product is Eroxon, a topical gel for the treatment of erectile dysfunction. It also develops WSD4000 for the treatment of sexual dysfunction in women. The company operates in the United Kingdom, the European Union, the United States, and internationally. Futura Medical plc was incorporated in 2001 and is headquartered in Guildford, the United Kingdom.

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 2001
• Employees: 14
• Stock Exchange: London Stock Exchange AIM
• Ticker Symbol: FUM